Personalizing Cardiology
The healthcare system spends significant resources managing the fallout from a cardiac event, but comparatively little is spent to assess risk beforehand.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Cardiovascular |
The healthcare system spends significant resources managing the fallout from a cardiac event, but comparatively little is spent to assess risk beforehand.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Dementias & Alzheimer’s, Heart Disease, Molecular Diagnostics |
Notable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read MorePosted by Jenny Lower | Jun 3, 2014 | Electrolytes, Uncategorized |
New products include the Hematek 3000 hematology analyzer from Siemens Healthcare Diagnostics, CoolCell alcohol-free cell-freezing containers from Biocision, and the Prostate Health Index from Beckman Coulter Diagnostics.
Read MorePosted by Steve Halasey | May 27, 2014 | Molecular Diagnostics |
Athena Diagnostics, the specialty neurology business of Quest Diagnostics, has unveiled 10 new epilepsy diagnostic services, including industry’s first clinical multianalyte test for autoimmune epilepsy.
Read MorePosted by Steve Halasey | Apr 11, 2014 | Cancer |
CDC’s grant of more than $1.25 million to the College of American Pathologists will help laboratory professionals improve the delivery of patient testing guidelines and cancer reporting.
Read More